Dennis Scharf is a physician and researcher. For his PhD he has joined the Department of Molecular Neuroimaging, headed by Prof. Gerhard Gründer, at the Central Institute of Mental Health (CIMH) in Mannheim, where he is primarily conducting clinical studies with a particular focus on psychedelic drugs. He is currently therapist and researcher in the German randomized controlled trial investigating the “Efficacy and Safety of Psilocybin in Treatment-Resistant Depression” (EPIsoDE).